专利检索 ap:("Idec Pharmaceuticals Corporation") AND inv:"WHITE, Christine, A." 第 1 页

1.

发明公开
TREATMENT OF INTERMEDIATE- AND HIGH-GRADE NON-HODGKINS LYMPHOMA WITH ANTI-CD20 ANTIBODY 审中-公开
标题翻译：非霍奇金淋巴瘤MIDDLE处理对高恶性肿瘤，抗CD20抗体

公开(公告)号：EP1227836A1

公开(公告)日：2002-08-07

申请号：EP00955249.8

申请日：2000-08-02

申请人： Idec Pharmaceuticals Corporation

发明人： WHITE, Christine, A. , GRILLO-LOPEZ, Antonio

IPC分类号： A61K39/00 , A61K49/16 , A61K51/00 , A61K51/10 , A61M36/06 , C07K16/28 , C12P21/08 , G01N33/15 , G01N33/50 , G01N33/53

CPC分类号： C07K16/2887 , A61K31/475 , A61K31/573 , A61K31/664 , A61K31/675 , A61K31/704 , A61K35/28 , A61K35/545 , A61K39/3955 , A61K39/39558 , A61K2039/505 , C07K2317/24 , Y10S424/801 , A61K2300/00

摘要： This invention discloses methods for the treatment of intermediate- and high-grade non-Hodgkins lymphomas comprising administration of anti-CD20 antibodies.

2.

发明公开
TREATMENT OF HEMATOLOGIC MALIGNANCIES ASSOCIATED WITH CIRCULATING TUMOR CELLS USING CHIMERIC ANTI-CD20 ANTIBODY 审中-公开
标题翻译：与循环肿瘤细胞使用嵌合抗CD20抗体相关治疗恶性血液病

公开(公告)号：EP1131093A1

公开(公告)日：2001-09-12

申请号：EP99960232.9

申请日：1999-11-09

申请人： IDEC PHARMACEUTICALS CORPORATION

发明人： GRILLO-LOPEZ, Antonio, J. , WHITE, Christine, A.

IPC分类号： A61K39/00

CPC分类号： C07K16/2887 , A61K31/196 , A61K31/573 , A61K31/675 , A61K31/7076 , A61K38/191 , A61K38/193 , A61K38/2026 , A61K38/212 , A61K39/395 , A61K39/3955 , A61K2039/505 , C23C2/02 , C23C2/06 , C23C2/30 , A61K2300/00

摘要： A method of treating hematologic malignancies associated with a high number of circulating tumor cells by the administration of a therapeutic chimeric anti-CD20 antibody. These malignancies include in particular B-prolymphocytic leukemia (B-PLL), chronic lymphocytic leukemia (CLL), and transformed non-Hodgkin's lymphoma.